Josh Disbrow

Josh Disbrow is vital to Zynex, Inc., a publicly-listed medical device enterprise specializing in electrotherapy and pain management. He holds a leadership position on the company's board in this capacity. He takes on the additional role of chairing the Nominating and Governance Committee, clearly indicating his steadfast commitment to upholding strong corporate governance principles. For his career, Josh has achieved significant milestones. Beginning as a sales representative at Glaxo Wellcome, his trajectory evolved to encompass pivotal commercial and leadership roles at several vital organizations. One noteworthy accomplishment occurred at Arbor Pharmaceuticals, where Josh played a central role as the company's second full-time employee. He led the company's transition from pre-commercialization to a remarkable achievement—generating over $250 million in revenue within five years. Academically, Josh's accomplishments provide a strong foundation for his industry expertise. After graduating with honors from North Carolina State University, he earned a Bachelor of Science in Management. He further honed his business acumen through the completion of a Master of Business Administration degree from Wake Forest University School of Business. Josh's dedication extends beyond professional pursuits into charity and philanthropy. Alongside his wife, he actively supports Colorado's Invest-in-Kids initiative. Their contributions extend to the annual Jane-A-Thon fundraiser, significantly benefiting the state's children and young families. Their generosity is further evident through regular donations to a local church and multiple charitable organizations. An exemplification of his commitment to service occurred during a recent mission trip to Puerto Penasco, Mexico, where he participated in constructing a home for a family in need. This commitment to giving back extends within Aytu BioPharma, where Josh ensures employees are granted a Volunteer Day, allowing them to dedicate their time to causes close to their hearts.